Holista Colltech Ltd (HCT) Fair Value & Analysis
Consumer Defensive · AU · Market cap A$29.4M
Strengths
Risks
Fair value as of: Aug 13, 2026
From 2 valuation models · updated 11 days ago
Share price −40.0% over the past month.
Below-average quality, trading 61% below our fair value.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The large discount to fair value meets weak quality (31/100). That raises the risk this is a value trap rather than a bargain.
- The price is below even our cautious bear case (A$0.0748). The market is more pessimistic than our downside scenario.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- A fairly wide model range (A$0.0748 to A$0.1664) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
60‑month range A$0.0050 – A$0.1100 · fair‑value band A$0.0748 – A$0.1664 · the A$0.0480 price screens below the A$0.1224 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Holista Colltech Ltd (HCT) currently trades at A$0.0480, while our model-based Fair Value estimate is A$0.1224, implying the stock looks roughly 155.0% undervalued today. The Quality Score stands at 31/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Over the trailing twelve months, Holista Colltech Ltd generated revenue of A$5.8M at a net margin of -16.4%. Revenue declined 2.1% year over year. Fundamentals as of Aug 13, 2026
Our scenario range runs from A$0.0748 (bear case) to A$0.1664 (bull case); at A$0.0480, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 56% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at 155%, HCT screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 2 models by family
Notify me when HCT reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 29 · Market factors (momentum, volatility) 10
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments.
Full company description
Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it offers GI LiTE, a premix glycemic index reducer, and LOGIC, a sweetening solution alternative for health-conscious consumers. The company also offers biogenic particles, low fat chips, and water soluble technology. Holista Colltech Limited is based in Subiaco, Australia.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Holista Colltech Ltd reported revenue of A$5.8M in FY2025 versus A$8.0M in FY2021, a compound −7.9%/yr. Reported net income was −A$949K in FY2025.
Watch HCT: get an alert when its fair value changes →
Peer Group
Packaged Foods · 666 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaged Foods median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé S.A NESN | CHF 79.06 | CHF 57.26 | -28% |
| Danone S.A BN | €65.48 | €48.41 | -26% |
| Nestlé India Limited NESTLEIND | ₹1,478 | ₹251.94 | -83% |
| The Kraft Heinz Company KHC | $24.53 | $24.59 | +0% |
| Foshan Haitian Flavouring and Food Company 603288 | ¥35.05 | ¥21.93 | -37% |
| Inner Mongolia Yili Industrial Group 600887 | ¥25.51 | ¥32.50 | +27% |
| Yihai Kerry Arawana Holdings 300999 | ¥25.28 | ¥9.89 | -61% |
| General Mills, Inc GIS | $38.18 | $28.32 | -26% |
| Wilmar International Limited F34 | 3.64 SGD | 3.89 SGD | +7% |
| McCormick & Company MKCV | $55.65 | $43.29 | -22% |
Compare Holista Colltech Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Holista Colltech Ltd (HCT) overvalued or undervalued?
What is the fair value of HCT?
What is the quality score of HCT?
What is the revenue of Holista Colltech Ltd (HCT)?
What is the net profit margin of HCT?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Holista Colltech Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.